Form 4 for CELU Celularity Inc
Accepted 2022-08-25 00:00:00 ET · period of report 2022-08-24 · accession 0000899243-22-029784 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-25 | 2022-08-24 | CELU | Hariri Robert J | CEO, Dir | M - OptEx | $2.87 | +119.1K | 7.98M | +2% | +$341.7K |
| D | 2022-08-25 | 2022-08-24 | CELU | Hariri Robert J | CEO, Dir | M - OptEx | $0.00 | -119.1K | 230.3K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-08-24 | M | A | 119,073 | $2.87 | 7,984,996 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-08-24 | M | D | 119,073 | $0.00 | 230,287 | D | $2.87 · — to 2031-07-16 | 119,073 Class A Common Stock | (F1) This option is fully vested and exercisable. |